@article{TCR13576,
author = {Federico Longo and Pablo Reguera and Alfredo Carrato},
title = {Ramucirumab efficacy in first-line gastric and esophageal cancer treatment},
journal = {Translational Cancer Research},
volume = {6},
number = {Suppl 3},
year = {2017},
keywords = {},
abstract = {Upper gastrointestinal cancers are highly lethal malignant diseases. Taken together gastric and esophageal (GE) cancers as a unique entity, both are estimated to be the third most incident and the second most lethal malignancies in both sexes worldwide. Despite the fact that GE cancer presents with a lower incidence in non-Asian countries with respect to Asian ones, its mortality is truly high in Occidental patients (29.3% survivors at 5 years) (1).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/13576}
}